DuChemBIO Co.,Ltd. (KOSDAQ:176750)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,920.00
+220.00 (2.27%)
At close: Oct 2, 2025
2.27%
Market Cap281.75B
Revenue (ttm)35.81B
Net Income (ttm)7.26B
Shares Out28.34M
EPS (ttm)262.40
PE Ratio37.88
Forward PE17.97
Dividendn/a
Ex-Dividend Daten/a
Volume30,350
Average Volume42,081
Open9,850.00
Previous Close9,700.00
Day's Range9,720.00 - 9,990.00
52-Week Range7,070.00 - 19,570.00
Beta0.03
RSI40.82
Earnings DateAug 14, 2025

About DuChemBIO

DuChemBIO Co.,Ltd. engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea. Its products include FP-CIT for diagnosis of Parkinson’s disease and Parkinson's syndrome by measuring the density of dopamine transporters present in the brain striatum; F-DOPA for brain tumor diagnosis with neutralization technology; Neuraceq for diagnosis of Alzheimer's disease by measuring the distribution and density of beta amyloid in the brain; and Vizamyl for early diagnosis of beta amylo... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2002
Employees 126
Stock Exchange KOSDAQ
Ticker Symbol 176750
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.